|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.97 INR | +2.04% |
|
+17.27% | -18.23% |
| Market Cap | 976M 10.32M 9.03M 8.34M 7.78M 14.66M 14.92M 100M 38.83M 482M 38.78M 37.91M 1.68B | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 14.22M 12.44M 11.49M 10.71M 20.19M 20.55M 138M 53.49M 663M 53.41M 52.22M 2.31B | EV / Sales 2024 |
12,382,225x | EV / Sales 2025 | 14,298,457x |
| Free-Float |
21.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.04% | ||
| 1 week | +17.27% | ||
| Current month | +28.44% | ||
| 1 month | +28.44% | ||
| 3 months | +28.74% | ||
| 6 months | -18.18% | ||
| Current year | -18.23% |
| 1 week | 33.25 |  | 41.25 |
| 1 month | 25.6 | | 41.25 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 70 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 12/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 06/08/2025 | |
| Compliance Officer | - | 13/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 08/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 74 | 04/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.04% | +17.27% | -32.24% | -7.37% | 14.25M | |
| -1.59% | +9.43% | +55.41% | +158.33% | 1,097B | |
| -0.79% | +7.24% | +67.85% | +54.90% | 622B | |
| -0.95% | +7.50% | +35.96% | +87.32% | 449B | |
| -1.62% | +6.34% | +29.51% | +24.01% | 334B | |
| -1.38% | +3.75% | +39.33% | +25.04% | 294B | |
| +0.30% | +2.56% | +31.62% | +40.64% | 286B | |
| -0.10% | +2.23% | -28.43% | -42.77% | 213B | |
| +0.21% | +4.08% | +29.36% | +62.68% | 195B | |
| -0.07% | +0.94% | +13.85% | +63.79% | 157B | |
| Average | -0.32% | +7.60% | +24.22% | +46.66% | 364.67B | |
| Weighted average by Cap. | -0.90% | +8.72% | +41.53% | +78.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.6 1.4 1.29 1.2 2.27 2.31 15.49 6.01 74.57 6 5.87 259.79 | 195.14 2.06 1.81 1.67 1.56 2.93 2.98 20 7.77 96.29 7.75 7.58 335.46 |
| Net income | -79.68M -843K -738K -681K -635K -1.2M -1.22M -8.17M -3.17M -39.32M -3.17M -3.1M -137M | -108M -1.14M -998K -921K -859K -1.62M -1.65M -11.05M -4.29M -53.18M -4.28M -4.19M -185M |
| Net Debt | 37.29M 394K 345K 319K 297K 560K 570K 3.82M 1.48M 18.4M 1.48M 1.45M 64.1M | 368M 3.9M 3.41M 3.15M 2.94M 5.53M 5.63M 37.75M 14.66M 182M 14.63M 14.31M 633M |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | ₹38.97 | +2.04% | 35,047 |
| 29/06/26 | ₹38.19 | +0.82% | 38,488 |
| 25/06/26 | ₹37.88 | +10.41% | 30,242 |
| 24/06/26 | ₹34.31 | -4.05% | 19,090 |
| 23/06/26 | ₹35.76 | +7.61% | 122,417 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
